Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma
Jian-Min Qin1, Pei-Hao Yin1, Qi Li1, Zhong-Qiu Sa1, Xia Sheng1, Lin Yang1, Tao Huang1, Min Zhang1, Ke-Pan Gao2, Qing-Hua Chen2, Jing-Wei Ma3, He-Bai Shen31Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, 2National Pharmaceutical Engineering Research...
Guardado en:
Autores principales: | Qin JM, Yin PH, Li Q, Sa ZQ, Sheng X, Yang L, Huang T, Zhang M, Gao KP, Chen QH, Ma JW, Shen HB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7b84a2aacfd84c3c908b61a3e34a82cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Study of pharmacokinetics and tissue distribution of liposomal brucine for dermal administration
por: Yang B-C, et al.
Publicado: (2011) -
In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine
por: Li S, et al.
Publicado: (2017) -
Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
por: Yong Jin, et al.
Publicado: (2021) -
EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
por: Yuko Kusakabe, et al.
Publicado: (2021) -
Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma
por: Xia L, et al.
Publicado: (2020)